Ulcerative Colitis Clinical Trials near Orlando, FL
20 studies for Ulcerative Colitis are recruiting at 28 sites within 50 miles of Orlando, Florida, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Orlando.
Recruiting now
Ulcerative Colitis studies enrolling near Orlando
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: AdventHealth Orlando - Site Number: 8400070 (Orlando, FL); Orlando Health, Inc. - Site Number: 8400084 (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: Endoscopic Research, Inc. (Orlando, FL); Orlando Health-Orlando Regional Medical Center (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Orlando Health (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Clinical Research of Osceola (Kissimmee, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Digestive And Liver Center Of Florida - Orlando /ID# 280924 (Orlando, FL); Clinical Research of Osceola /ID# 280593 (Kissimmee, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Advent Health (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126
- Phase 2
- Ages 12 to 17 years
- Sex: All
Nearest site: Arnold Palmer Hospital - Center for Digestive Health and Nutrition (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
NCT05987852
- Interventional
- Ages 18 to 85 years
- Sex: All
Nearest site: Orlando Health (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest site: Endoscopic Research Inc (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Mirador Therapeutics Selected Site (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Zymfentra (Infliximab-dyyb) REal World Cohort STudy
NCT07237516
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: AdventHealth (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315
- Phase 2
- Ages 16 years and older
- Sex: All
Nearest site: Orlando Gastroenterology, P.A. (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
NCT07463183
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: AdventHealth Orlando ( Site 1074) (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Site US-026 (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626
- Observational
- Ages 18 to 64 years
- Sex: All
Nearest site: Digestive and Liver Center of Florida Kissimmee (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990
- Phase 1/2
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Xencor Investigative Site (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Clinical Research of Osceola, LLC (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Site 007 (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07185009
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Clinical Research of Osceola - Site Number: 8400013 (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Clinical Research of Osceola (Kissimmee, FL)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.